Funzione ovarica e chemioterapia in donne affette da carcinoma della mammella
Agnese Barnabei(National Cancer Institute), Marialuisa Appetecchia(Istituti di Ricovero e Cura a Carattere Scientifico), Francesco Torino(University of Rome Tor Vergata), Liana De Vecchis(National Cancer Institute), Agnese Persichetti(National Cancer Institute), Salvatore Maria Corsello(Università Cattolica del Sacro Cuore), Roberto Baldelli(University of Turin), Aurora De Leo(National Cancer Institute)
Cited by 0
Related Papers
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index
|European Journal of Endocrinology|2005|317
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer
|Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|2016|151
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
|Breast Cancer Research and Treatment|2006|140
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors
|The Oncologist|2014|103
Nurse specialist and ostomy patient: Competence and skills in the care pathway. A scoping review
|Journal of Clinical Nursing|2023|33